Combination of Methotrexate and Leflunomide Is Safe and Has Good Drug Retention Among Patients With Psoriatic Arthritis

J Rheumatol. 2021 Oct;48(10):1624-1626. doi: 10.3899/jrheum.201408. Epub 2021 May 15.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antirheumatic Agents* / adverse effects
  • Arthritis, Psoriatic* / drug therapy
  • Humans
  • Leflunomide / therapeutic use
  • Methotrexate / adverse effects
  • Pharmaceutical Preparations*

Substances

  • Antirheumatic Agents
  • Pharmaceutical Preparations
  • Leflunomide
  • Methotrexate